» Articles » PMID: 7606788

The Large Diverse Gene Family Var Encodes Proteins Involved in Cytoadherence and Antigenic Variation of Plasmodium Falciparum-infected Erythrocytes

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1995 Jul 14
PMID 7606788
Citations 507
Authors
Affiliations
Soon will be listed here.
Abstract

The human malaria parasite Plasmodium falciparum evades host immunity by varying the antigenic and adhesive character of infected erythrocytes. We describe a large and extremely diverse family of P. falciparum genes (var) that encode 200-350 kDa proteins having the expected properties of antigenically variant adhesion molecules. Predicted amino acid sequences of var genes show a variable extracellular segment with domains having receptor-binding features, a transmembrane sequence, and a terminal segment that is a probable submembrane anchor. There are 50-150 var genes on multiple parasite chromosomes, and some are in clustered arrangements. var probes detect two classes of transcripts in steady-state RNA: 7-9 kb var transcripts, and an unusual family of 1.8-2.4 kb transcripts that may be involved in expression or rearrangements of var genes.

Citing Articles

Breaking a barrier: In trans vlsE recombination and genetic manipulation of the native vlsE gene of the Lyme disease pathogen.

Singh P, Bankhead T PLoS Pathog. 2025; 21(1):e1012871.

PMID: 39792948 PMC: 11756760. DOI: 10.1371/journal.ppat.1012871.


Human antibodies offer broad inhibition against variable proteins of the malaria parasite.

Tran T Nature. 2024; 636(8041):54-55.

PMID: 39567799 DOI: 10.1038/d41586-024-03555-3.


Broadly inhibitory antibodies to severe malaria virulence proteins.

Reyes R, Raghavan S, Hurlburt N, Introini V, Bol S, Kana I Nature. 2024; 636(8041):182-189.

PMID: 39567685 DOI: 10.1038/s41586-024-08220-3.


The histone methyltransferase PfSET10 is dispensable for the regulation of antigenic variation and gene expression in blood-stage parasites.

Wyss M, Kanyal A, Niederwieser I, Bartfai R, Voss T mSphere. 2024; 9(11):e0054624.

PMID: 39445826 PMC: 11580404. DOI: 10.1128/msphere.00546-24.


Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Vidal-Calvo E, Martin-Salazar A, Choudhary S, Dagil R, Raghavan S, Duvnjak L Nat Commun. 2024; 15(1):7553.

PMID: 39215044 PMC: 11364678. DOI: 10.1038/s41467-024-51781-0.